Creation and Validation of a Semi-quantitative Instrument to Assess the Confidence of Pharmacists in Medication Consultation for Patients with Depression: The Pharmacists' Confidence Scale About Medication Consultation for Depressive Patients (PCMCD)

Overview

Journal Pharm Pract (Granada)

Date 2020 Jan 4

PMID 31897261

Citations 2

Authors

Masaki Shoji

Atsuko Fujiwara

Mitsuko Onda

Affiliations

Soon will be listed here.

Abstract

Objectives: To develop a semi-quantitative instrument to assess pharmacists' confidence in medication counseling for patients with depression, The Pharmacists' Confidence scale about Medication Consultation for Depressive patients (PCMCD), and investigated its validity.

Methods: Following discussions with practicing pharmacists, we developed a 12-item questionnaire to assess pharmacists' confidence in medication counseling for patients with depression. We launched web-based cross-sectional survey during November and December 2018 to 77 pharmacists employed at drug chain stores in Kansai area. Factor analysis was performed to evaluate the configuration concept validity. The least-squares method was used for factor extraction, and the resulting factors were subjected to direct oblimin rotation, with a factor loading cut-off of 0.4. To assess internal consistency, Cronbach's alpha values were calculated for each of the extracted factors (subscales). A multiple regression analysis was performed using simultaneous forced entry, with the scores obtained for each subscale as dependent variables and responder attributes as independent variables in order to investigate the factors associated with each subscale.

Results: During the factor analysis procedure, four questions were excluded by the cut-off rule. Eventually, a model with three subscales was identified, with a cumulative sum of squared loadings being 61.9%. The subscales were termed "relationship building," "comprehension of condition," and "information provision" based on the nature of the questions relevant for each of them. The Cronbach's alpha values for these subscales were 0.92, 0.73, and 0.72, respectively. The average inter-item correlation was 0.378. In addition, multiple regression analysis revealed that there were significant correlations between pharmacist career and both relationship building and information provision.

Conclusions: The PCMCD model demonstrated a satisfactory construct validity and internal consistency. This model will provide an excellent tool for assessing pharmacists' confidence in depression care.

Citing Articles

A non-randomized, controlled, interventional study to investigate the effects of community pharmacists' cognitive behavioral therapy-based interventions on medication adherence and relevant indicators in patients with depression.

Shoji M, Maeda H, Watanabe F, Tanuma K, Fujiwara A, Iwanaga Y BMC Psychiatry. 2023; 23(1):124.

PMID: 36829184 PMC: 9951417. DOI: 10.1186/s12888-023-04602-5.

Pharmaceutical Care in Depression: A Survey of Stigma, Confidence, Attitudes, and Barriers.

Soliman M Risk Manag Healthc Policy. 2020; 13:2611-2620.

PMID: 33235531 PMC: 7678506. DOI: 10.2147/RMHP.S273365.

References

Liekens S, Smits T, Laekeman G, Foulon V . A depression training session with consumer educators to reduce stigmatizing views and improve pharmacists' depression care attitudes and practices. Am J Pharm Educ. 2013; 77(6):120. PMC: 3748301. DOI: 10.5688/ajpe776120. View

Demyttenaere K . Compliance during treatment with antidepressants. J Affect Disord. 1997; 43(1):27-39. DOI: 10.1016/s0165-0327(96)00095-x. View

Scheerder G, De Coster I, Van Audenhove C . Pharmacists' role in depression care: a survey of attitudes, current practices, and barriers. Psychiatr Serv. 2008; 59(10):1155-60. DOI: 10.1176/ps.2008.59.10.1155. View

McLaughlin K . The public health impact of major depression: a call for interdisciplinary prevention efforts. Prev Sci. 2011; 12(4):361-71. PMC: 3219837. DOI: 10.1007/s11121-011-0231-8. View

Onitilo A, Nietert P, Egede L . Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. Gen Hosp Psychiatry. 2006; 28(5):396-402. DOI: 10.1016/j.genhosppsych.2006.05.006. View

Lyketsos C, Lopez O, Jones B, Fitzpatrick A, Breitner J, DeKosky S . Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA. 2002; 288(12):1475-83. DOI: 10.1001/jama.288.12.1475. View

Everitt B . Multivariate analysis: the need for data, and other problems. Br J Psychiatry. 1975; 126:237-40. DOI: 10.1192/bjp.126.3.237. View

Botega N, Silveira G . General practitioners attitudes towards depression: a study in primary care setting in Brazil. Int J Soc Psychiatry. 1996; 42(3):230-7. DOI: 10.1177/002076409604200307. View

Brook O, van Hout H, Stalman W, Nieuwenhuyse H, Bakker B, Heerdink E . A pharmacy-based coaching program to improve adherence to antidepressant treatment among primary care patients. Psychiatr Serv. 2005; 56(4):487-9. DOI: 10.1176/appi.ps.56.4.487. View

10.

Tanaka G, Ogawa T, Inadomi H, Kikuchi Y, Ohta Y . Effects of an educational program on public attitudes towards mental illness. Psychiatry Clin Neurosci. 2003; 57(6):595-602. DOI: 10.1046/j.1440-1819.2003.01173.x. View

11.

Scheerder G, De Coster I, Van Audenhove C . Community pharmacists' attitude toward depression: a pilot study. Res Social Adm Pharm. 2009; 5(3):242-52. DOI: 10.1016/j.sapharm.2008.08.008. View

12.

Bultman D, Svarstad B . Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy. J Am Pharm Assoc (Wash). 2002; 42(1):36-43. DOI: 10.1331/108658002763538053. View

13.

Keller M, Boland R . Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biol Psychiatry. 1998; 44(5):348-60. DOI: 10.1016/s0006-3223(98)00110-3. View

14.

Kessler R, Angermeyer M, Anthony J, de Graaf R, Demyttenaere K, Gasquet I . Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World Psychiatry. 2008; 6(3):168-76. PMC: 2174588. View

15.

Boudreau D, Capoccia K, Sullivan S, Blough D, Ellsworth A, Clark D . Collaborative care model to improve outcomes in major depression. Ann Pharmacother. 2002; 36(4):585-91. DOI: 10.1345/aph.1A259. View

16.

Finley P, Rens H, Pont J, Gess S, Louie C, Bull S . Impact of a collaborative pharmacy practice model on the treatment of depression in primary care. Am J Health Syst Pharm. 2002; 59(16):1518-26. DOI: 10.1093/ajhp/59.16.1518. View

17.

Poluzzi E, Piccinni C, Sangiorgi E, Clo M, Tarricone I, Menchetti M . Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherence. Eur J Clin Pharmacol. 2013; 69(12):2095-101. DOI: 10.1007/s00228-013-1567-8. View

18.

Al-Jumah K, Qureshi N . Impact of pharmacist interventions on patients' adherence to antidepressants and patient-reported outcomes: a systematic review. Patient Prefer Adherence. 2012; 6:87-100. PMC: 3277799. DOI: 10.2147/PPA.S27436. View

19.

Empana J, Jouven X, Lemaitre R, Sotoodehnia N, Rea T, Raghunathan T . Clinical depression and risk of out-of-hospital cardiac arrest. Arch Intern Med. 2006; 166(2):195-200. DOI: 10.1001/archinte.166.2.195. View

20.

Haddad M, Walters P, Tylee A . District nursing staff and depression: a psychometric evaluation of Depression Attitude Questionnaire findings. Int J Nurs Stud. 2006; 44(3):447-56. DOI: 10.1016/j.ijnurstu.2006.07.005. View